Clarivate Plc

NYSE:CLVT 주식 리포트

시가총액: US$1.2b

Clarivate 배당 및 자사주 매입

배당 기준 점검 0/6

Clarivate 배당금을 지급한 기록이 없습니다.

핵심 정보

n/a

배당 수익률

12.7%

자사주 매입 수익률

총 주주 수익률12.7%
미래 배당 수익률0%
배당 성장률n/a
다음 배당 지급일n/a
배당락일n/a
주당 배당금n/a
배당 성향n/a

최근 배당 및 자사주 매입 업데이트

업데이트 없음

Recent updates

내러티브 업데이트 • Sep 03

CLVT: Rebuilding Effort And AI Expansion May Support Future Cash Flow

Clarivate’s analyst price target has been revised from $2.50 to $2.00, with analysts citing an extended timeline for the company’s effort to rebuild its foundations as the primary reason for the change. Analyst Commentary Recent commentary on Clarivate focuses on how much time it may take for the company to rebuild its foundations and what that could mean for the stock’s valuation and execution risk.
내러티브 업데이트 • Aug 14

CLVT: AI Platforms And Rebuilding Efforts Will Support Future Upside

Analysts have lowered their implied fair value for Clarivate from $6.00 to about $5.32, reflecting recent cuts in Street price targets from $2.50 to $2.00 as some see the company’s foundation rebuilding efforts taking longer to play out. Analyst Commentary Recent research on Clarivate highlights mixed views, with some analysts focusing on the time needed for the company to rebuild its foundations and others flagging areas where execution could support a more constructive outlook on valuation.
내러티브 업데이트 • Jul 30

CLVT: Fair Value View Will Balance AI Progress Against Prolonged Rebuilding Risks

Clarivate's analyst price target has been revised down from $2.50 to $2.00. Analysts point to the time required for the company to rebuild its foundations and reflect this more cautious view in lower fair value and profit margin assumptions, along with a higher future P/E estimate.
내러티브 업데이트 • Jul 07

CLVT: Portfolio Sale And AI Investments May Support Future Cash Flow

Clarivate's analyst price target has been adjusted slightly higher to $2.50 from $2.40. Analysts attribute the change to updated views on fair value, future P/E assumptions and profitability as key drivers of the revision.
내러티브 업데이트 • Jun 22

CLVT: IP Leadership And AI Platforms Will Drive Future Upside

Analysts have kept their $6.00 price target on Clarivate unchanged, citing updated assumptions that now reflect a slightly higher discount rate, modestly adjusted revenue growth and profit margin expectations, and a broadly similar future P/E outlook. What’s in the News for Clarivate Clarivate appointed Simon Webster as President of its Intellectual Property segment, effective June 10, as Maroun S.
내러티브 업데이트 • Jun 07

CLVT: Fair Value View Balances AI Platform Rollout Against Ongoing Profitability Risks

Analysts have revised their Clarivate price target to $2.40, reflecting updated assumptions about slower revenue declines, lower profit margins, and a higher future P/E of 71.88x in their models. What's in the News Clarivate launched IPOne, a unified IP intelligence platform that uses purpose-built AI agents and proprietary data to support IP research and workflows across enterprises, including activities such as discovery, clearance, prioritization, monitoring, analysis and decision support.
내러티브 업데이트 • May 23

CLVT: Free Cash Flow May Offset AI And Portfolio Execution Risks

Analysts have trimmed Clarivate price targets into a roughly $2.40 to $6 range, citing concerns around AI-related disruption risks and execution questions on the planned Life Sciences and Healthcare unit sale, even as some highlight solid free cash flow performance and guidance. Analyst Commentary Recent research notes reflect a mixed but generally cautious stance on Clarivate, with most firms trimming price targets while keeping ratings unchanged.
Seeking Alpha • May 13

Clarivate: Business Showed Signs Of Stabilization, But It Is Not Enough

Summary Clarivate delivered improved Q1 2026 results, with organic growth turning positive at 0.6% and margin expansion, but reported revenue still declined year over year. Segment trends stabilized, notably with Academia & Government and Life Sciences & Healthcare returning to growth, though IPPG remained a drag at -1.3% organic growth. AI-driven product enhancements and the Value Creation Plan could accelerate organic growth, but sustained improvement is needed before a re-rating is justified. I maintain a hold rating, seeking several more quarters of cleaner execution and stronger IPPG performance before turning more constructive. Read the full article on Seeking Alpha
내러티브 업데이트 • May 06

CLVT: Life Sciences Sale Execution Will Drive Upside Despite AI Risk

Analysts have trimmed their price expectations for Clarivate, with new targets ranging roughly from $2.40 to $6.00. They cited concerns around AI-related disruption risks and execution on the planned Life Sciences and Healthcare asset sale.
내러티브 업데이트 • Apr 21

CLVT: Free Cash Flow And Portfolio Simplification May Support Future Upside Potential

The Analyst Price Target for Clarivate has been reduced by about $1, with analysts pointing to AI disintermediation risk and uncertainty around the planned Life Sciences and Healthcare unit sale as key reasons for the reset. Analyst Commentary Recent research points to a more cautious stance on Clarivate, with several banks trimming price targets while keeping a range of ratings from Underweight to Buy.
내러티브 업데이트 • Apr 07

CLVT: Fair Value View Weighs AI Disruption Against Portfolio Reshaping Risks

Analyst price targets on Clarivate have reset sharply lower into a $2.40 to $6 range, with cuts of up to about $2 to $2.60 as analysts factor in AI disruption risks and uncertainty around the planned Life Sciences and Healthcare segment sale. Analyst Commentary Recent research updates on Clarivate highlight a cautious tilt, with several bearish analysts resetting expectations lower despite references to solid free cash flow metrics and outlined growth targets.
내러티브 업데이트 • Mar 24

CLVT: Fair Value View Balances AI Competition With Portfolio Execution Risks

Clarivate's analyst price targets have moved lower toward a new implied fair value near $2.40 per share, as analysts factor in slower revenue growth assumptions, lower profit margin expectations, AI related competitive risks, and execution risk around the planned Life Sciences and Healthcare unit sale. Analyst Commentary Recent Street research on Clarivate has tilted more cautious, with several bearish analysts cutting price targets and, in one case, downgrading the stock.
내러티브 업데이트 • Mar 10

CLVT: Value Creation Plan Execution Will Drive Upside Despite AI Headwinds

Our analyst price target for Clarivate has moved down from $7.00 to $6.00 as analysts trim their targets across the Street. They cite AI related competitive pressures, the execution risk around a potential Life Sciences and Healthcare sale, and a longer timeline for the company’s Value Creation Plan to play out.
내러티브 업데이트 • Feb 24

CLVT: Extended Plan Execution Will Unlock Value Despite Rising AI Competition

Analysts have trimmed their $4.20 price target on Clarivate to $3.60, reflecting concerns that rising competition from AI-focused rivals, limits on pricing power, and a longer timeline for the company's "Value Creation Plan" temper expectations for organic revenue growth and profitability. Analyst Commentary Goldman Sachs cut its rating on Clarivate to Neutral from Buy and reduced its price target to $3.60 from $4.20, signaling a more cautious stance on the shares.
내러티브 업데이트 • Feb 09

CLVT: Extended Value Creation Plan Timeline May Support Future Upside Potential

Analysts have trimmed their price target on Clarivate to about US$3.60 from roughly US$4.20, citing a longer timeline for the company's "Value Creation Plan" to influence organic revenue growth, as well as concerns about pressure from AI driven competitors and limited pricing power. Analyst Commentary Bullish Takeaways Bullish analysts still see some value support around the revised US$3.60 target, suggesting expectations have been reset to reflect slower organic growth execution.
분석 기사 • Feb 04

Clarivate Plc's (NYSE:CLVT) 35% Dip In Price Shows Sentiment Is Matching Revenues

Clarivate Plc ( NYSE:CLVT ) shareholders that were waiting for something to happen have been dealt a blow with a 35...
내러티브 업데이트 • Jan 25

CLVT: Extended Plan And AI Competition Will Shape Long-Term Execution Outlook

Analysts have trimmed their price target on Clarivate to $3.60 from $4.20, citing expectations for a longer timeline for the Value Creation Plan to influence organic revenue growth, as well as concerns around competition from AI focused peers and limited pricing power. Analyst Commentary Recent Street research reflects a more cautious stance on Clarivate, with at least one major firm reducing its rating and target price as expectations temper around execution of the Value Creation Plan and the pace of organic revenue growth.
내러티브 업데이트 • Jan 09

CLVT: Extended Value Creation Timeline Will Confront Intensifying AI Competition

Analysts have trimmed their fair value estimate for Clarivate from US$3.75 to US$3.00, citing a lower Street price target and expectations that the company’s "Value Creation Plan" and efforts to improve organic revenue growth may take longer to show results in the face of rising AI driven competition and limited pricing power. Analyst Commentary Recent Street commentary has turned more cautious on Clarivate, with some price targets cut and ratings pulled back as expectations around the "Value Creation Plan" are reset to a longer timetable.
내러티브 업데이트 • Dec 22

CLVT: Share Repurchases Will Support Future Earnings Upside

Analysts have trimmed their price target on Clarivate by approximately $0.25. This reflects slightly higher perceived risk via a modestly increased discount rate and a lower future earnings multiple, while leaving their long term growth and profitability assumptions essentially unchanged.
내러티브 업데이트 • Dec 08

CLVT: Share Buybacks And Raised Guidance Will Support Future Performance

Analysts have slightly lowered their price target on Clarivate to reflect modestly reduced discount rate assumptions and a marginally lower future price-to-earnings multiple, while keeping their fair value estimate effectively unchanged at approximately $4.93 per share. What's in the News Clarivate completed a share repurchase of 34,823,885 shares, representing 5.11% of outstanding shares, for a total of $149.47 million under its December 16, 2024 buyback authorization (Key Developments).
내러티브 업데이트 • Nov 24

CLVT: Strong Market Share Will Support Future Performance Despite AI Risk

Analysts have slightly raised their price target for Clarivate to nearly $5 per share. They cite the firm’s solid market position but note ongoing risks from budget constraints, AI competition, and leverage concerns.
내러티브 업데이트 • Nov 09

CLVT: Market Position And AI Developments Will Drive Performance Ahead

Analysts have lowered Clarivate's price target from approximately $5.14 to $4.93 per share. They cite concerns over budget constraints in key sectors, potential risks from artificial intelligence, and the company’s elevated leverage, despite its strong market position.
분석 기사 • Sep 16

These 4 Measures Indicate That Clarivate (NYSE:CLVT) Is Using Debt Extensively

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
분석 기사 • Aug 02

Earnings Update: Clarivate Plc (NYSE:CLVT) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts

One of the biggest stories of last week was how Clarivate Plc ( NYSE:CLVT ) shares plunged 20% in the week since its...
분석 기사 • Jul 26

Is There An Opportunity With Clarivate Plc's (NYSE:CLVT) 32% Undervaluation?

Key Insights Clarivate's estimated fair value is US$6.63 based on 2 Stage Free Cash Flow to Equity Clarivate's US$4.53...
분석 기사 • Jul 08

At US$4.40, Is Clarivate Plc (NYSE:CLVT) Worth Looking At Closely?

While Clarivate Plc ( NYSE:CLVT ) might not have the largest market cap around , it led the NYSE gainers with a...
User avatar
새로운 내러티브 • May 11

Subscription Model And AI Integration Will Drive Operational Efficiency

Transitioning to a subscription-based model and AI innovation enhances revenue stability and competitive edge, supporting growth and improving net margins.
분석 기사 • May 04

Optimistic Investors Push Clarivate Plc (NYSE:CLVT) Shares Up 27% But Growth Is Lacking

Clarivate Plc ( NYSE:CLVT ) shareholders are no doubt pleased to see that the share price has bounced 27% in the last...
분석 기사 • Apr 23

Clarivate Plc (NYSE:CLVT) Shares Could Be 33% Below Their Intrinsic Value Estimate

Key Insights Clarivate's estimated fair value is US$4.92 based on 2 Stage Free Cash Flow to Equity Current share price...
분석 기사 • Apr 08

Should You Investigate Clarivate Plc (NYSE:CLVT) At US$3.37?

Clarivate Plc ( NYSE:CLVT ), is not the largest company out there, but it saw significant share price movement during...

지급의 안정성과 성장

배당 데이터 가져오는 중

안정적인 배당: 과거에 CLVT 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.

배당금 증가: CLVT 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.

배당 수익률 vs 시장

Clarivate 배당 수익률 vs 시장
CLVT의 배당 수익률은 시장과 어떻게 비교되나요?
구분배당 수익률
회사 (CLVT)n/a
시장 하위 25% (US)1.4%
시장 상위 25% (US)4.1%
업계 평균 (Professional Services)2.3%
분석가 예측 (CLVT) (최대 3년)0%

주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 CLVT 의 배당 수익률을 평가할 수 없습니다.

고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 CLVT 의 배당 수익률을 평가할 수 없습니다.

주주 대상 이익 배당

수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 CLVT 의 지급 비율을 계산하기에는 데이터가 부족합니다.

주주 현금 배당

현금 흐름 범위: CLVT 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.

높은 배당을 제공하는 우량 기업 찾기

7D

1Y

7D

1Y

7D

1Y

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/09/13 10:00
종가2026/09/11 00:00
수익2026/06/30
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.

Simply Wall St 분석 모델을 설계하고 구축한 에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Clarivate Plc는 13명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Manav PatnaikBarclays
Heather BalskyBofA Global Research
Zachary CumminsB. Riley Securities, Inc.